-
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18 Apr 2024 21:08 GMT
Geron Corporation (Nasdaq: GERN), a late-stage … options to new employees.
About Geron
Geron is a late-stage clinical … Prize-winning science in a treatment that may alter the underlying … (NDA) for imetelstat for the treatment of transfusion dependent anemia in …
-
Geron To Present At Needham Virtual Healthcare Conference; Webcast At 10:15 AM ET
10 Apr 2024 13:39 GMT
Geron Corporation (GERN) will present at the … to https://www.geron.com
For comments and feedback …
-
Geron to Participate at Upcoming Investor Conferences in April
03 Apr 2024 20:47 GMT
Geron Corporation (Nasdaq: GERN), a late-stage … website for 30 days.
About Geron
Geron is a late-stage clinical … Prize-winning science in a treatment that may alter the underlying … (NDA) for imetelstat for the treatment of transfusion dependent anemia in …
-
Geron to Participate at Upcoming Investor Conferences in April
03 Apr 2024 20:40 GMT
Geron Corporation (Nasdaq: GERN), a late-stage … website for 30 days.
About Geron
Geron is a late-stage clinical … Prize-winning science in a treatment that may alter the underlying … (NDA) for imetelstat for the treatment of transfusion dependent anemia in …
-
Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
19 Mar 2024 13:38 GMT
Geron Corporation (Nasdaq: GERN), a late-stage … conditions.
The gross proceeds to Geron from this underwritten offering, … or other jurisdiction.
About Geron
Geron is a late-stage biopharmaceutical … Prize winning science in a treatment that may alter the …
-
FDA Adcomm Backs Geron’s Anemia Drug for Blood Cancer
15 Mar 2024 15:23 GMT
… 12–2 in favor of Geron Corporation, finding that its investigational … 47;risk profile for the treatment of transfusion-dependent anemia in … side effects for imetelstat treatment could be managed by … that the risks of treatment with imetelstat are outweighed …
-
Geron leaps as ODAC backs its MDS drug imetelstat
15 Mar 2024 11:06 GMT
… its imetelstat therapy as a treatment for myelodysplastic syndromes (MDS).
The … receive treatment with erythropoiesis-stimulating agents (ESAs) for anaemia.
Shares in Geron … cause cytopenias.
“There are few treatment options and significant unmet medical …
-
FDA adcomm votes in favor of Geron's anemia drug for cancer patients despite questions on risk
14 Mar 2024 22:23 GMT
… benefits of Geron’s imetelstat outweigh safety risks for the treatment of …
-
What's Going On With Cancer Focused-Geron Stock On Friday?
15 Mar 2024 15:56 GMT
Friday, Geron Corporation’s GERN shares are trading … risks and toxicities of the treatment appear to be manageable.
… Imetelstat will be Geron’s first commercial treatment in the market and … TI outweigh the risks of treatment with imetelstat for patients with …
-
Geron Gets Favorable Votes From FDA Panel For Imetelstat In Treating Transfusion-Dependent Anemia
15 Mar 2024 02:54 GMT
Geron Corp. (GERN) said Thursday that … profile of imetelstat for the treatment of transfusion-dependent anemia … Geron's New Drug Application for imetelstat for the treatment … recommendations are not binding. Geron plans to commercially launch imetelstat …